[ad_1]
As a result of the two new health and economic crises in the country, which prevented the availability of all required drugs in the local market, and given that some drugs are very expensive, and within the framework of the work to control and reduce health spending , especially in the field of medicine, and based on Law No. 207 issued on 12/30/2020, which authorized the pharmacist to replace the prescribed drug with a generic drug without the approval of the treating physician, and within the conditions and specific controls, the General Director of the National Social Security Fund, Muhammad Karaki, issued Memorandum No. 5, dated 12/01/2021, according to which he decided to grant the pharmacist authority to replace The drug is generic without referring to the treating physician nor obtain your written consent, and that is within the controls and conditions established in the new article 47, especially if the medicine is less expensive and of the same quality and guaranteed consent of the patient for replacement.
[ad_2]
Consequently, all users are obliged to accept, filter and disburse transactions contained in generic alternatives for the benefit of the content.
The statement adds: “On this occasion, Karki renews its commitment to do everything necessary to facilitate and guarantee the rights of the insured, and hopes that pharmacists adhere to the good application of the new article 47, especially with regard to the alternative medicine that is covered by fund regulations and contains the same composition and efficacy and lower price and guaranteed patient approval. ” substitution”.
